January 2, 2018 / 10:30 PM / in a year

SEC seeks penalty, 5-year ban for ex-Aveo Pharmaceuticals exec

BOSTON (Reuters) -

The U.S. Securities and Exchange Commission is pushing to have the former chief medical officer of Aveo Pharmaceuticals Inc pay a $150,000 penalty and be barred for five years from serving as an officer or director of a public company for committing fraud.

The motion filed by the SEC on Friday in federal court in Boston came after William Slichenmyer reached a settlement in October in which he would neither admit nor deny wrongdoing but leave to the court to determine if he should pay a penalty and face a ban.

To read the full story on WestlawNext Practitioner Insights, click here: bit.ly/2EDIzyR

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below